InvestorsHub Logo
Followers 16
Posts 4426
Boards Moderated 4
Alias Born 12/06/2018

Re: trusttheman post# 13386

Wednesday, 04/03/2024 4:43:16 PM

Wednesday, April 03, 2024 4:43:16 PM

Post# of 13724

"From all these observations, we conclude that the clinical study of HemoStyp versus Surgicel was likely a failure. However, if and when its PMA application gets rejected, we doubt that shareholders will hear about it. We expect it will be just like when UEEC applied for PMA approval for Class III in late 2017, there will just not be any updates, like it never happened."


https://seekingalpha.com/article/4300303-united-health-products-press-releases-cannot-be-taken-face-value
Bearish
Bearish